DiaMedica Therapeutics Inc. Annual Operating Income (Loss) in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
DiaMedica Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2024.
  • DiaMedica Therapeutics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$8.42M, a 44% decline year-over-year.
  • DiaMedica Therapeutics Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$26.7M, a 25.5% decline year-over-year.
  • DiaMedica Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$26.7M, a 25.5% decline from 2023.
  • DiaMedica Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$21.3M, a 51.9% decline from 2022.
  • DiaMedica Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$14M, a 2.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$26.7M -$5.41M -25.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 -$21.3M -$7.27M -51.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 -$14M -$355K -2.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$13.6M -$947K -7.46% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 -$12.7M -$1.11M -9.54% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 -$11.6M -$4.83M -71.5% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-10
2018 -$6.76M -$2.24M -49.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
2017 -$4.52M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.